Objective To develop consensus recommendations on urine drug monitoring (UDM) in
patients with chronic pain who are prescribed opioids. Methods An interdisciplinary group of …

Over the past few decades, research has revealed high rates of substance-related disorders
among patients with chronic pain. In addition to their potentially deleterious health …

ABSTRACT BACKGROUND Urine drug testing (UDT) can help identify misuse or diversion
of opioid medications among patients with chronic pain. However, misinterpreting results …

Background: Patients treated for chronic pain may frequently undergo urine drug testing to
monitor medication compliance and detect undisclosed prescribed or illicit drug use. Due to …

Objective The primary objective of this study was to measure prescribing compliance with
the Veterans Affairs/Department of Defense treatment guidelines for chronic non-cancer …

Background: Therapeutic use, overuse, abuse, and diversion of controlled substances in
managing chronic non-cancer pain continues to be an issue for physicians and patients. It …

Background: Despite hints about the high incidence of pain patients misreporting their pain
medication use, there are only a few non-controlled studies on the topic that focus solely on …

Background Urine drug testing (UDT) is an essential tool to monitor opioid misuse among
patients on chronic opioid therapy. Inaccurate interpretation of UDT can have deleterious …

Background: Enzyme immunoassays (EIA) have notable limitations for monitoring
therapeutic compliance in pain management. Chromatography coupled with mass …

Urine buprenorphine screening is utilized to assess buprenorphine compliance and to
detect illicit use. Robust screening assays should be specific for buprenorphine without …